However, APP/PS1 double transgenic mice are among the most successful models, promptly developing memory and cognitive impairments and other relevant pathological process, such as Aβ deposition and a robust neuroinflammatory response toward senile plaques, along with synaptic integrity loss [11]. The gene discussed is PSEN1; the disease is Senile plaques.